Screener
IDEAYA Biosciences, Inc. IDYA Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $8.86M— | $6.56M— | $10.88M+55.4% | $207.83M— | —— | ||
| $108.69M+46.4% | $95.73M+35.0% | $86.6M-38.2% | $82.99M+45.2% | $74.23M+36.1% | ||
| $22.46M+54.0% | $19.38M+43.5% | $18.85M+72.0% | $16.39M+68.2% | $14.58M+40.3% | ||
| $131.15M+47.7% | $115.1M+36.4% | $105.45M-30.2% | $99.38M+48.6% | $88.81M+36.8% | ||
| -$122.29M-37.7% | -$108.54M-28.6% | -$94.57M+34.4% | $108.45M+262% | -$88.81M-36.8% | ||
| -1,380.7%— | -1,654.6%— | -869.5%+1,190pp | 52.2%— | —— | ||
| $9.84M-13.0% | $10.01M-18.1% | $11.3M-18.3% | $10.79M-28.4% | $11.32M-6.9% | ||
| -$112.45M-45.1% | -$98.54M-36.5% | -$83.27M+36.1% | $119.24M+330% | -$77.49M-46.8% | ||
| -1,269.6%— | -1,502.1%— | -765.7%+1,096pp | 57.4%— | —— | ||
| -$1.22-38.6% | -$1.11-35.4% | -$0.94+39.4% | $1.33+322% | -$0.88-29.4% | ||
| -$121.6M-38.0% | -$107.86M-28.7% | -$93.85M+34.6% | $109.11M+265% | -$88.09M-37.0% | ||
| -1,373%— | -1,644.1%— | -862.9%+1,188pp | 52.5%— | —— | ||
| -$122.29M-37.7% | -$108.54M-28.6% | -$94.57M+34.4% | $108.45M+262% | -$88.81M-36.8% |
FAQ
- What is IDEAYA Biosciences, Inc.'s revenue?
- IDEAYA Biosciences, Inc. (IDYA) generated $234.1M in revenue over the trailing twelve months.
- Is IDEAYA Biosciences, Inc. profitable?
- IDEAYA Biosciences, Inc. is not currently profitable: it reported a net loss of $175.0M over the trailing twelve months, a -74.8% net margin.
- What is IDEAYA Biosciences, Inc.'s earnings per share?
- IDEAYA Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-1.94.
- Where does IDEAYA Biosciences, Inc.'s income statement data come from?
- Every line is extracted from IDEAYA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
